Skip to main content
Log in

Treatment of ribavirin-induced haemolytic anaemia not costly

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treatment of ribavirin-induced haemolytic anaemia not costly. Pharmacoecon. Outcomes News 339, 6 (2001). https://doi.org/10.1007/BF03280643

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03280643

Keywords

Navigation